Dr. Alexis Kalergis

"Human Metapneumovirus causes high morbidity in the population, especially in infants and the elderly." The severity of this virus is the second cause of childhood pneumonia. Our team has developed a safe and effective vaccine against this virus. This has shown excellent protection results in pre-clinical studies.We are currently carrying out the clinical studies necessary to bring this vaccine onto the market and reduce the impact of this disease in the Chilean and international population."

Research Line / Vaccines
Project:
Safe and effective vaccines against Human Metapneumovirus (hMPV)

Dra. Susan Bueno

"Diagnostic tests only detect viruses, they do not detect bacteria, nor do they report on the severity of inflammatory response and the severity of infection. All of this along with the high costs of current testing creates the challenge and opportunity to develop one test that detects the multiple infectious agents in the respiratory tract in a specific, sensitive and simultaneous way and that detects some gravity and prognosis parameters of the patient so the doctor may decide on the best treatment option.”

Research / Diagnostic Line
Project:
Immunological Tools to Detect Respiratory Pathogens

Dr. Carlos Fardella

"The development of this project has allowed us to generate a multidisciplinary knowledge platform in order to collaborate in solving the problem of the increasing incidence of metabolic diseases in our population and at a global level."

Research / Therapy Line
Project:
Development of new drugs for the treatment of hypertension and metabolic syndrome

Dra. Carolina Llanos

"Today there are more than 5 million young women in the world affected by Lupus and their treatments have a high cost in terms of adverse reactions. It is motivating to be able to work on better treatment strategies that give women an improved and better quality of life". "BMRC has been fundamental in this process, providing us with strategic support and technological tools, as well as having a vision of technology transfer with a product that finely reaches patients".

Research Line / Therapy
Project:
Autologous based immunotherapy on tolerogenic dendritic cells for Systemic Lupus Erythematosus (SLE)

Dr. Hernán González

"Globally, there are 600,000 cases of thyroid cancer annually. However, there is not one test to predict the aggressiveness of this illness in order to choose more precise treatments according to the patient's profile. After the development of a thyroid cancer diagnostic test - known as Thyrioprint - it was logical to follow up with a second test that could predict with high accuracy the biological behavior of the tumor. Knowing how aggressive the cancer is can change the definitive treatment of the profile of the patient prior to surgery.”

Research Line / Diagnostics
Project:
Thyroid Cancer Prognosis Test

BMRC AND VACCINE FOR HUMAN METAPNEUMOVIRUS (HMPV) IN PORTAFOLIO SALUD MAGAZINE.

BMRC: 1st BOARD OF DIRECTORS MEETING OF 2017

UC BETS ON ALLIANCES THAT SUPPORT RESEARCH IN BIOMEDICINE

SAFE AND EFFECTIVE VACCINE AGAINST HUMAN METAPNEUMOVIRUS (HMPV)

Patents Map

Patents Applied for

Patents Granted

Dr. Alexis Kalergis

Dra. Susan Bueno

Dr. Carlos Fardella

Dra. Carolina Llanos

Dr. Hernán González